Valine

Valine

SCHEMBL7961940

CC(C)[C@H](N)C(=O)O.NC(=O)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSD P07339 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.46
▸ TSHR P16473 2/20 0.44
▸ GLA P06280 1/20 0.43
▸ SLC7A5 Q01650 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42
▸ RELA Q04206 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ADAMTS4 O75173 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE4D Q08499 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valine SCHEMBL7169984 0.90 TSHR (0.53) CTSDALDH1A1TSHRGLASLC7A5
SCHEMBL115478 0.83 CTSD (0.65) CTSDALDH1A1TSHRNPC1GAA
SCHEMBL10766788 0.83 CTSD (0.65) CTSDALDH1A1TSHRNPC1GAA
Hydrochloric Acid SCHEMBL8025084 0.81 CTSD (0.62) CTSDALDH1A1TSHRNPC1GAA
Hydrochloric Acid SCHEMBL10550781 0.81 CTSD (0.62) CTSDALDH1A1TSHRNPC1GAA
Nitrobenzene SCHEMBL9768008 0.79 ALDH1A1 (0.55) ALDH1A1TSHRSLC7A5NPC1RAB9A
Alcohol SCHEMBL6835144 0.79 CTSD (0.60) CTSDALDH1A1TSHRGAASMN1; SMN2
Anthranilamide SCHEMBL2834554 0.77 SLC7A5 (0.50) ALDH1A1TSHRSLC7A5GAAMAPT
Sodium Chloride SCHEMBL9877634 0.77 CTSD (0.57) CTSDALDH1A1TSHRNPC1GAA
Alanine SCHEMBL27675387 0.75 MAPK1 (0.51) CTSDALDH1A1TSHRGLANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218393-B1 IN THERAPY OF MULTIDRUG RESISTANT CANCERS, FOR EXAMPLE TO POTENTIATE CYTOTOXICITY OF CANCER DRUG XENOVA LIMITED (GB) 2001-04-17 — — US disclosed
Send feedback